BRAF and melanoma: It has been shown that mutations of proteins in the RAS/RAF/MAPK pathway promote glycolysis [11] and the expression of cell surface glucose transporter 1 (GLUT1) in both colorectal cancer cell lines [12] and in melanoma [13] indicating that glucose metabolism might be important for BRAF-driven tumourigenesis.